Bausch Health Companies (BHC) Goodwill & Intangibles (2009 - 2026)
Bausch Health Companies (BHC) reported Goodwill & Intangibles of $14.2 billion for Q1 2026, down 13.61% on a YoY basis from $16.4 billion in Q1 2025, and down 10.7% sequentially from $15.9 billion in Q4 2025.
Bausch Health Companies (BHC) Goodwill & Intangibles (2009 - 2026) Analysis & Trends
Bausch Health Companies (BHC) has 18 years of Goodwill & Intangibles data on file, last reported at $14.2 billion in Q1 2026.
- For the quarter ending Q1 2026, Goodwill & Intangibles fell 13.61% year-over-year to $14.2 billion; the trailing twelve-month figure through Mar 2026 stood at $14.2 billion (down 13.61% YoY), and the FY2025 full-year result was $15.9 billion, down 4.35% from the prior year.
- Goodwill & Intangibles slipped to $14.2 billion in Q1 2026, from $15.9 billion in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $19.1 billion in Q1 2022 to a low of $6.5 billion in Q3 2022.
- A 5-year average of $15.8 billion and a median of $16.8 billion in 2024 frame the typical range for Goodwill & Intangibles.
- Across the five-year window, Goodwill & Intangibles tumbled 67.04% in 2022 and jumped 112.41% in 2024, its largest moves.
- Tracing BHC's Goodwill & Intangibles over 5 years: stood at $17.3 billion in 2022, then gained by 1.68% to $17.6 billion in 2023, then slipped by 5.67% to $16.6 billion in 2024, then decreased by 4.35% to $15.9 billion in 2025, then fell by 10.7% to $14.2 billion in 2026.
- Business Quant data shows BHC's Goodwill & Intangibles at $14.2 billion in Q1 2026, $15.9 billion in Q4 2025, and $16.1 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.21 Bn |
| Dec 31, 2025 | 15.91 Bn |
| Sep 30, 2025 | 16.12 Bn |
| Jun 30, 2025 | 16.35 Bn |
| Mar 31, 2025 | 16.45 Bn |
| Dec 31, 2024 | 16.64 Bn |
| Sep 30, 2024 | 16.82 Bn |
| Jun 30, 2024 | 17.03 Bn |
| Mar 31, 2024 | 17.34 Bn |
| Dec 31, 2023 | 17.64 Bn |
| Sep 30, 2023 | 7.92 Bn |
| Jun 30, 2023 | 16.93 Bn |
| Mar 31, 2023 | 17.13 Bn |
| Dec 31, 2022 | 17.35 Bn |
| Sep 30, 2022 | 6.50 Bn |
| Jun 30, 2022 | 18.59 Bn |
| Mar 31, 2022 | 19.06 Bn |
| Dec 31, 2021 | 19.41 Bn |
| Sep 30, 2021 | 19.74 Bn |
| Jun 30, 2021 | 20.15 Bn |